{"id":54,"date":"2011-10-19T14:40:21","date_gmt":"2011-10-19T18:40:21","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/ipcp\/?page_id=54"},"modified":"2012-05-17T16:04:06","modified_gmt":"2012-05-17T20:04:06","slug":"projects","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/ipcp\/projects\/","title":{"rendered":"Projects"},"content":{"rendered":"<ul>\n<li><strong>Project 1: <\/strong><a title=\"Project 1 Description\" href=\"https:\/\/www.bumc.bu.edu\/ipcp\/project-1-critical-path-project-mapp66-a-multi-antibody-prevention-product\/\">Critical Path Project:\u00a0 Mapp66, a Multi-antibody Prevention Product <\/a><\/li>\n<li style=\"text-align: left;\"><em>A.\u00a0 Mapp Pharmaceutical<\/em>\n<ul>\n<li style=\"text-align: left;\">PI:\u00a0 Kevin J. Whaley, PhD<\/li>\n<li style=\"text-align: left;\">Co-PI:\u00a0 Larry Zeitlin, PhD<\/li>\n<li style=\"text-align: left;\">Co-I:\u00a0 Michael Pauly, PhD<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\"><em>B. \u00a0Kentucky BioProcessing<\/em>\n<ul>\n<li style=\"text-align: left;\">Co-I: \u00a0Barry\u00a0Bratcher<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\"><em>C.\u00a0 Aridis Pharmaceutical<\/em>\n<ul>\n<li style=\"text-align: left;\">Co-I:\u00a0 Vu Truong, PhD\u00a0<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\"><strong>Project 2: <\/strong><a title=\"Project 2 Description\" href=\"https:\/\/www.bumc.bu.edu\/ipcp\/project-2-mabs-in-the-cervicovaginal-environment-cellular-interactions-and-host-defense\/\">MAbs in the Cervicovaginal Environment:\u00a0 Cellular Interactions and Host Defense <\/a>\n<ul>\n<li style=\"text-align: left;\">PI:\u00a0 Deborah J. Anderson, PhD<\/li>\n<li style=\"text-align: left;\">Co-I:\u00a0 Joseph A. Politch, PhD<\/li>\n<li style=\"text-align: left;\">Co-I:\u00a0 Jeffrey Pudney, PhD<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\"><strong>Project 3: <\/strong><a title=\"Project 3 Description\" href=\"https:\/\/www.bumc.bu.edu\/ipcp\/project-3-optimizing-plantibodies-for-trapping-hiv-and-hsv-in-cervicovaginal-mucus\/\">Optimizing Plantibodies for Trapping HIV and HSV in Cervicovaginal Mucus <\/a><\/li>\n<li style=\"text-align: left;\"><em>A.\u00a0 University of North Carolina at Chapel Hill<\/em>\n<ul>\n<li style=\"text-align: left;\">PI:\u00a0 Samuel K. Lai, PhD<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\"><em>B.\u00a0 Johns Hopkins University<\/em>\n<ul>\n<li style=\"text-align: left;\">Co-PI:\u00a0 Richard Cone, PhD<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\"><strong>Project 4: <\/strong><a title=\"Project 4 Description\" href=\"https:\/\/www.bumc.bu.edu\/ipcp\/project-4-vaginal-mab-delivery-systems\/\">Vaginal mAb Delivery Systems <\/a><\/li>\n<li style=\"text-align: left;\"><em>A.\u00a0 ReProtect<\/em>\n<ul>\n<li style=\"text-align: left;\">PI:\u00a0 Thomas R. Moench, MD<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\"><em>B.\u00a0 Auritec<\/em>\n<ul>\n<li style=\"text-align: left;\">Co-PI:\u00a0 Thomas Smith, PhD<\/li>\n<li style=\"text-align: left;\">Co-I:\u00a0 Amanda M. Malone, PhD<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\"><strong>Project 5: <\/strong><a title=\"Project 5 Description\" href=\"https:\/\/www.bumc.bu.edu\/ipcp\/project-5-pre-clinical-evaluation-of-mab-microbicide-products-in-nonhuman-primates\/\">Pre-Clinical Evaluation of mAb Microbicide Products in Nonhuman Primates <\/a>\n<ul>\n<li style=\"text-align: left;\">PI:\u00a0 Francois Villinger, DVM, PhD<\/li>\n<li style=\"text-align: left;\">Co-PI:\u00a0 Prachi Sharma, DVM, PhD<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\"><strong>Project 6: <\/strong><a title=\"Project 6 Description\" href=\"https:\/\/www.bumc.bu.edu\/ipcp\/project-6-a-pharmacokinetic-and-pharmacodynamic-study-of-an-antibody-based-vaginal-microbicide\/\">A Pharmacokinetic and Pharmacodynamic Study of an Antibody-Based Vaginal Microbicide <\/a><\/li>\n<li>\n<div style=\"text-align: left;\"><em>A.\u00a0 Fenway Health<\/em><\/div>\n<ul>\n<li style=\"text-align: left;\">PI:\u00a0 Kenneth H. Mayer, MD<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\"><em>B. The Miriam Hospital<\/em>\n<ul>\n<li style=\"text-align: left;\">Co-PI:\u00a0 Susan Cu-Uvin, MD<\/li>\n<li style=\"text-align: left;\">Co-I:\u00a0 Kathleen Morrow, PhD<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Project 1: Critical Path Project:\u00a0 Mapp66, a Multi-antibody Prevention Product A.\u00a0 Mapp Pharmaceutical PI:\u00a0 Kevin J. Whaley, PhD Co-PI:\u00a0 Larry Zeitlin, PhD Co-I:\u00a0 Michael Pauly, PhD B. \u00a0Kentucky BioProcessing Co-I: \u00a0Barry\u00a0Bratcher C.\u00a0 Aridis Pharmaceutical Co-I:\u00a0 Vu Truong, PhD\u00a0 Project 2: MAbs in the Cervicovaginal Environment:\u00a0 Cellular Interactions and Host Defense PI:\u00a0 Deborah J. Anderson, PhD [&hellip;]<\/p>\n","protected":false},"author":2546,"featured_media":0,"parent":0,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/pages\/54"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/users\/2546"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/comments?post=54"}],"version-history":[{"count":30,"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/pages\/54\/revisions"}],"predecessor-version":[{"id":149,"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/pages\/54\/revisions\/149"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/media?parent=54"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}